LUNG CANCER IMMUNOTHERAPY

  • Neringa Vagulienė
DOI: https://doi.org/10.37499/PIA.217
Keywords: lung cancer, immune system, mmunotherapy, cytotoxic T-lymphocyte-associated antigen 4(CTLA-4), programmed cell death protein-1 (PD-1), programmed cell death ligand-1 (PD-L1)

Abstract

The immune system plays a crucial role in protecting the body against cancer by recognizing and destroying cells it perceives as foreign. Cancer immunity strategies aim to restore immunity systems abilities to mobilize an antitumor immune response. Immunotherapy is an existing area of cancer research and treatment, which is showing promising results for people with advanced lung cancers.

Author Biography

Neringa Vagulienė

Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences

How to Cite
1.
Vagulienė N. LUNG CANCER IMMUNOTHERAPY [Internet]. PIA 2017 Sep.;1(2):140-144.[cited 2024 Nov. 22 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/217
Issue
Vol 1 No 2 (2017): Pulmonology and Allergology
Section
Pharmacotherapy